SLAMF7 and neoplasm: In this study, we found that the levels of IL‐12 and SLAMF7 expressed by clinical tumor patients were not sufficient to regulate the tumor immunosuppressive microenvironment (TIME), as determined through analysis of clinical databases and the Human Protein Atlas.